Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands.
Wirtz PW, van Dijk JG, van Doorn PA, van Engelen BG, van der Kooi AJ, Kuks JB, Twijnstra A, de Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Among authors: visser lh, de visser m. Neurology. 2004 Jul 27;63(2):397-8. doi: 10.1212/01.wnl.0000130254.27019.14. Neurology. 2004. PMID: 15277653 No abstract available.
The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands.
van der Kooi AJ, Barth PG, Busch HF, de Haan R, Ginjaar HB, van Essen AJ, van Hooff LJ, Höweler CJ, Jennekens FG, Jongen P, Oosterhuis HJ, Padberg GW, Spaans F, Wintzen AR, Wokke JH, Bakker E, van Ommen GJ, Bolhuis PA, de Visser M. van der Kooi AJ, et al. Among authors: de haan r, de visser m. Brain. 1996 Oct;119 ( Pt 5):1471-80. doi: 10.1093/brain/119.5.1471. Brain. 1996. PMID: 8931572
Epidemiology of inclusion body myositis in the Netherlands: a nationwide study.
Badrising UA, Maat-Schieman M, van Duinen SG, Breedveld F, van Doorn P, van Engelen B, van den Hoogen F, Hoogendijk J, Höweler C, de Jager A, Jennekens F, Koehler P, van der Leeuw H, de Visser M, Verschuuren JJ, Wintzen AR. Badrising UA, et al. Among authors: de jager a, de visser m. Neurology. 2000 Nov 14;55(9):1385-7. doi: 10.1212/wnl.55.9.1385. Neurology. 2000. PMID: 11087787
HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor.
Wirtz PW, Roep BO, Schreuder GM, van Doorn PA, van Engelen BG, Kuks JB, Twijnstra A, de Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Among authors: visser lh, de visser m. Hum Immunol. 2001 Aug;62(8):809-13. doi: 10.1016/s0198-8859(01)00270-1. Hum Immunol. 2001. PMID: 11476904
Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome.
Wirtz PW, Sotodeh M, Nijnuis M, Van Doorn PA, Van Engelen BG, Hintzen RQ, De Kort PL, Kuks JB, Twijnstra A, De Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Among authors: de kort pl, visser lh, de visser m. J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):766-8. doi: 10.1136/jnnp.73.6.766. J Neurol Neurosurg Psychiatry. 2002. PMID: 12438488 Free PMC article.
Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.
Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, Maat-Schieman ML, van Doorn P, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, van Duinen SG; Dutch IBM Study Group. Badrising UA, et al. Among authors: de jager ae, de visser m. Neurology. 2004 Dec 28;63(12):2396-8. doi: 10.1212/01.wnl.0000148588.15052.4c. Neurology. 2004. PMID: 15623710
The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients.
Titulaer MJ, Wirtz PW, Kuks JB, Schelhaas HJ, van der Kooi AJ, Faber CG, van der Pol WL, de Visser M, Sillevis Smitt PA, Verschuuren JJ. Titulaer MJ, et al. Among authors: de visser m. J Neuroimmunol. 2008 Sep 15;201-202:153-8. doi: 10.1016/j.jneuroim.2008.05.025. Epub 2008 Jul 21. J Neuroimmunol. 2008. PMID: 18644631
Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo.
Badrising UA, Maat-Schieman ML, Ferrari MD, Zwinderman AH, Wessels JA, Breedveld FC, van Doorn PA, van Engelen BG, Hoogendijk JE, Höweler CJ, de Jager AE, Jennekens FG, Koehler PJ, de Visser M, Viddeleer A, Verschuuren JJ, Wintzen AR. Badrising UA, et al. Among authors: de jager ae, de visser m. Ann Neurol. 2002 Mar;51(3):369-72. doi: 10.1002/ana.10121. Ann Neurol. 2002. PMID: 11891832 Clinical Trial.
Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients.
Badrising UA, Maat-Schieman ML, van Houwelingen JC, van Doorn PA, van Duinen SG, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, Verschuuren JJ, Wintzen AR. Badrising UA, et al. Among authors: de jager ae, de visser m. J Neurol. 2005 Dec;252(12):1448-54. doi: 10.1007/s00415-005-0884-y. Epub 2005 Jun 17. J Neurol. 2005. PMID: 15942703
508 results